biote Corp. logo

biote Corp.

BTMD | NASDAQ
Chart Builder DCF Calculator
$1.17
+$0.06 (+5.41%)
Nov 2, 2026, 12:46 PM ET · Market open

Company Profile

Biote Corp. is dedicated to supporting and developing medical practices that focus on hormone optimization. The company provides a comprehensive system for its Biote-certified healthcare professionals, enabling them to correct imbalances in patients' hormone, vitamin, and mineral levels. This includes authorizing the prescription of bioidentical hormone treatments and suggesting suitable dietary supplements. Furthermore, Biote offers its own line of branded nutritional supplements and supplies sterile kits for inserting hormone pellets for both male and female individuals. Founded in 2011, Biote Corp. is based in Irvine, Texas.

Key Executives

Name Position
Robert Peterson Interim CEO, CFO & Chief Business Officer
Joel Pickering Chief Marketing Officer
John J. Olsen Chief Information Officer
Cory Rice Chief Clinical Advisor & Member of Medical Advisory Board
Dan Monico General Counsel
Jade Beutler Head of Nutraceuticals
Joey Lopes SVP of Strategy & Commercial Operations
Komal Bajaj Chief Medical Officer
Marc D. Beer Executive Chairman
Richard Kevin Key Chief Digital Officer

Latest SEC Filings

Date Type Title
Sep 18, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Sep 01, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Aug 28, 2026 SC 13G Statement of acquisition of beneficial ownership b...
Aug 12, 2026 4 Filing
Aug 07, 2026 10-Q Quarterly Report
Aug 05, 2026 8-K Current Report
Jul 27, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Jun 17, 2026 8-K/A [Amend] Current Report
Jun 16, 2026 4 Filing
Jun 10, 2026 4 Filing
View All SEC Filings ➞
biote Corp.
biote Corp. logo
Country United States
IPO Date Apr 28, 2021
Industry Medical - Care Facilities
Sector Healthcare
Employees 223
CEO Robert C. Peterson

Contact Details

1875 West Walnut Hill Lane Irving, Texas 75038 United States

Stock Details

Ticker Symbol BTMD
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001819253
CUSIP Number 090683103
ISIN Number US0906831039
SIC Code 2833

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.